These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 20156410

  • 21. Prevalence of tardive dyskinesia among psychiatric in-patients at Mathari Hospital, Nairobi.
    Gatere N, Othieno CJ, Kathuku DM.
    East Afr Med J; 2002 Oct; 79(10):547-9. PubMed ID: 12635762
    [Abstract] [Full Text] [Related]

  • 22. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
    Chacko RC, Root L, Marmion J, Molinari V, Adams GL.
    J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
    [Abstract] [Full Text] [Related]

  • 23. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.
    Ganzini L, Heintz RT, Hoffman WF, Casey DE.
    Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743
    [Abstract] [Full Text] [Related]

  • 24. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J, Lima MS, Costa AN, Alexandrino N, Rodrigues-Filho S, de Oliveira IR, Tollefson GD.
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [Abstract] [Full Text] [Related]

  • 25. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD, Eudicone JM, Pikalov A, Kim E.
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [Abstract] [Full Text] [Related]

  • 26. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
    Keck PE, McElroy SL, Strakowski SM, Soutullo CA.
    J Clin Psychiatry; 2000 Dec; 61 Suppl 4():33-8. PubMed ID: 10739329
    [Abstract] [Full Text] [Related]

  • 27. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
    Ryu S, Yoo JH, Kim JH, Choi JS, Baek JH, Ha K, Kwon JS, Hong KS.
    J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636
    [Abstract] [Full Text] [Related]

  • 28. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
    Correll CU, Leucht S, Kane JM.
    Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
    [Abstract] [Full Text] [Related]

  • 29. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR, McPhillips MA.
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [Abstract] [Full Text] [Related]

  • 30. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.
    Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL, McAdams LA.
    Arch Gen Psychiatry; 1995 Sep; 52(9):756-65. PubMed ID: 7654127
    [Abstract] [Full Text] [Related]

  • 31. Nithsdale Schizophrenia Surveys 23: movement disorders. 20-year review.
    Halliday J, Farrington S, Macdonald S, MacEwan T, Sharkey V, McCreadie R.
    Br J Psychiatry; 2002 Nov; 181():422-7. PubMed ID: 12411269
    [Abstract] [Full Text] [Related]

  • 32. Antipsychotics-induced tardive syndrome: a retrospective epidemiological study.
    Lee MJ, Lin PY, Chang YY, Chong MY, Lee Y.
    Clin Neuropharmacol; 2014 Nov; 37(4):111-5. PubMed ID: 24992086
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.
    Gebhardt S, Härtling F, Hanke M, Mittendorf M, Theisen FM, Wolf-Ostermann K, Grant P, Martin M, Fleischhaker C, Schulz E, Remschmidt H.
    Eur Child Adolesc Psychiatry; 2006 Oct; 15(7):371-82. PubMed ID: 16648965
    [Abstract] [Full Text] [Related]

  • 34. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM, Yu SC, Lin CC.
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.